Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Astellas Pharma Ltd
3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 24/04/2012
PIL Advagraf 0.5mg, 1mg, 3mg and 5mg Prolonged-release hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/04/2012 and displayed until Current
Reasons for adding or updating:
  • Updates to formatting
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 05/01/2012 and displayed until 24/04/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 24/11/2011 and displayed until 05/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to side-effects
Updated on 28/01/2011 and displayed until 24/11/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 11/05/2010 and displayed until 28/01/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 28/07/2009 and displayed until 11/05/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Introduction of new strength
Updated on 28/07/2009 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Introduction of new strength
Updated on 08/01/2009 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/09/2008 and displayed until 08/01/2009
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 20/08/2008 and displayed until 26/09/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Introduction of new pack/pack size
Updated on 12/05/2008 and displayed until 20/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 06/07/2007 and displayed until 12/05/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  tacrolimus monohydrate